#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	14564	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2101	689.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1439	1439	C	880	C	813	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26794	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3561	750.2	0	.	n	.	0	T695C	SNP	695	695	T	1021	1021	C	868	C,T	805,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26794	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3561	750.2	0	.	n	.	0	G1337A	SNP	1337	1337	G	1663	1663	A	916	A,G	837,4	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26794	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3561	750.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2297	2297	C	890	C	813	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26794	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3561	750.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2371	2371	A	898	A	825	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26794	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3561	750.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	2923	2923	C	812	C,A	756,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1856	folP	855	855	100.0	folP.l15.c17.ctg.1	1428	129.4	1	SNP	p	R229S	1	.	.	685	687	AGC	940	942	AGC	173;174;176	A;G;C	159;161;162	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4846	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3282	147.0	1	SNP	p	S91F	1	.	.	271	273	TTC	486	488	TTC	172;171;173	T;T,C;C	153;153,1;156	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4846	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3282	147.0	1	SNP	p	D95G	1	.	.	283	285	GGC	498	500	GGC	171;174;175	G;G,A;C,A	157;159,2;161,1	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4846	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3282	147.0	1	SNP	p	G95N	0	.	.	283	285	GGC	498	500	GGC	171;174;175	G;G,A;C,A	157;159,2;161,1	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1566	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1216	127.8	1	SNP	p	G45D	0	.	.	133	135	GGC	426	428	GGC	222;224;221	G;G,T;C	203;205,1;199	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	766	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	909	83.3	0	.	n	.	0	A197.	DEL	197	197	A	486	486	A	189	A	174	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4870	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2973	163.4	1	SNP	p	D86N	0	.	.	256	258	GAC	579	581	GAC	183;184;187	G;A;C	170;166;172	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4870	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2973	163.4	1	SNP	p	R87I	0	.	.	259	261	CGT	582	584	CGT	186;186;187	C,A;G;T	171,1;172;174	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4870	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2973	163.4	1	SNP	p	S87R	1	.	.	259	261	CGT	582	584	CGT	186;186;187	C,A;G;T	171,1;172;174	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4870	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2973	163.4	1	SNP	p	R87W	0	.	.	259	261	CGT	582	584	CGT	186;186;187	C,A;G;T	171,1;172;174	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4870	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2973	163.4	1	SNP	p	S88P	0	.	.	262	264	TCC	585	587	TCC	188;186;185	T;C;C,A	172;171;170,1	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3974	parE	1986	1986	100.0	parE.l6.c17.ctg.1	2524	156.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1486	1488	GGC	199;197;193	G;G;C	179;177;176	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	3550	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2450	144.3	1	SNP	p	A311V	0	.	.	931	933	GCA	1282	1284	GCA	209;205;201	G;C;A	183;181;183	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3550	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2450	144.3	1	SNP	p	I312M	0	.	.	934	936	ATC	1285	1287	ATC	203;203;201	A;T;C	183;185;181	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3550	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2450	144.3	1	SNP	p	V316P	0	.	.	946	948	GTG	1297	1299	GTG	203;201;202	G;T;G	183;182;184	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3550	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2450	144.3	1	SNP	p	V316T	0	.	.	946	948	GTG	1297	1299	GTG	203;201;202	G;T;G	183;182;184	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3550	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2450	144.3	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1801	1803	ACC	180;176;173	A;C;C	163;163;160	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3550	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2450	144.3	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1855	1857	GCG	163;163;160	G;C;G	144;138;139	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3550	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2450	144.3	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1855	1857	GCG	163;163;160	G;C;G	144;138;139	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3550	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2450	144.3	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1978	1980	AGC	181;177;179	A,G;G;C	168,1;165;160	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3550	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2450	144.3	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1987	1989	GGC	170;169;167	G;G;C,T	154;151;148,1	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3550	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2450	144.3	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2005	2007	CCG	135;138;139	C,G;C;G	98,5;100;103	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5284	ponA	2397	2397	100.0	ponA.l15.c30.ctg.1	3066	171.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1584	1586	CCG	191;190;189	C;C;G	172;174;173	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2092	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1723	120.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	585	585	C	148	C	135	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	304	porB1a	984	112	91.96	porB1a.l15.c30.ctg.1	379	34.3	0	.	p	.	0	M18T	NONSYN	52	54	ATG	233	235	ACG	69;67;64	A;C;G	63;61;57	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	304	porB1a	984	112	91.96	porB1a.l15.c30.ctg.1	379	34.3	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	275	277	CAA	33;29;29	C;A;A	32;28;28	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	304	porB1a	984	112	91.96	porB1a.l15.c30.ctg.1	379	34.3	0	.	p	.	0	S34Y	NONSYN	100	102	TCC	281	283	TAC	23;21;20	T;A;C	23;21;20	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2906	porB1b	1047	1047	99.14	porB1b.l6.c4.ctg.1	1460	196.9	0	.	p	.	0	N38E	NONSYN	112	114	AAT	345	347	GAA	256;258;255	G;A;A	233;232;230	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2906	porB1b	1047	1047	99.14	porB1b.l6.c4.ctg.1	1460	196.9	0	.	p	.	0	N134D	NONSYN	400	402	AAT	633	635	GAT	248;249;249	G;A;T	229;231;230	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2906	porB1b	1047	1047	99.14	porB1b.l6.c4.ctg.1	1460	196.9	0	.	p	.	0	P175S	NONSYN	523	525	CCA	756	758	TCA	220;221;219	T;C;A	204;206;205	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2906	porB1b	1047	1047	99.14	porB1b.l6.c4.ctg.1	1460	196.9	0	.	p	.	0	A218V	NONSYN	652	654	GCC	885	887	GTC	229;226;224	G,T;T,C;C	207,1;203,1;205	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2906	porB1b	1047	1047	99.14	porB1b.l6.c4.ctg.1	1460	196.9	0	.	p	.	0	F222S	NONSYN	664	666	TTT	897	899	TCT	224;226;227	T,C;C,T;T	209,1;215,1;217	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2906	porB1b	1047	1047	99.14	porB1b.l6.c4.ctg.1	1460	196.9	0	.	p	.	0	H294R	NONSYN	880	882	CAT	1113	1115	CGT	241;242;247	C,G;G,A;T	224,1;225,1;230	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2906	porB1b	1047	1047	99.14	porB1b.l6.c4.ctg.1	1460	196.9	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1215	1217	GCA	251;253;252	G;C,A;A	229;231,2;234	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2906	porB1b	1047	1047	99.14	porB1b.l6.c4.ctg.1	1460	196.9	1	SNP	p	G120K	1	.	.	358	360	AAG	591	593	AAG	265;267;265	A;A;G	241;243;237	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2906	porB1b	1047	1047	99.14	porB1b.l6.c4.ctg.1	1460	196.9	1	SNP	p	A121D	1	.	.	361	363	GAC	594	596	GAC	265;260;261	G;A;C	237;231;233	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2906	porB1b	1047	1047	99.14	porB1b.l6.c4.ctg.1	1460	196.9	1	SNP	p	D121N	0	.	.	361	363	GAC	594	596	GAC	265;260;261	G;A;C	237;231;233	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10820	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	4746	227.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1182	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1002	117.2	1	SNP	p	V57M	1	.	.	169	171	ATG	538	540	ATG	241;242;241	A,G;T;G	232,1;234;234	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
